Emcor Group Faces 49 Decline Since Latest Earnings Report What Investors Should Consider InMed Pharmaceuticals Q3 2025 Earnings EPS of 194 Reflects RD Investment as Stock Declines 655 AI Cost Surge Forces CFOs to Choose Between Tokens and Talent